Plus Therapeutics, Inc.
PSTV · NASDAQ
Market closed$3.74$-0.160000 (-4.10%)After hours $3.68 · -1.60%
Key statistics
Previous close$3.90
Open$3.78
Day high$3.96
Day low$3.59
52-week high$23.50
52-week low$2.90
Market cap9.05M
Volume215.14K
Average volume192.55K
P/E ratio-1.93
Forward P/E—
EPS-1.93
Dividend yield0.00%
Market context
Why it moved
PSTV shares declined today amid broader market selling pressure and a lack of positive catalysts, as no significant company-specific news was available to support the stock's prior price levels.
What is happening
Recent company-specific developments and publisher coverage.
Investing.com · July 16, 2026Plus Therapeutics partners with GTC on CSF diagnostic platformStock Titan · July 16, 2026Cancer guidelines broaden spinal-fluid analysis; Plus plans DNA, RNAStock Titan · July 14, 2026Guidelines call for spinal-fluid checks every 4–8 weeks during therapyTradingView · July 14, 2026PSTV: Cerenome advances CNS oncology with integrated therapeutics, diagnostics, and native AIStock Titan · June 30, 2026Plus Therapeutics rebrands as Cerenome, ticker CNSY starts Aug. 3Contract Pharma · April 23, 2026Plus Therapeutics Initiates Manufacturing Activities, Tech Transfer With SpectronRxStocktwits · April 10, 2026PSTV Stock On Track For Best Week Since September — Here’s What Is Driving The RallyInvesting.com · April 8, 2026Plus Therapeutics stock gains after FDA orphan drug nod